Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
ZYCUBO is a copper histidinate injection for the treatment of Menkes disease, a rare genetic copper deficiency disorder in pediatric patients. It is the first and only FDA-approved bioavailable copper replacement therapy, administered subcutaneously to deliver elemental copper to the body.
Parse Score